全文获取类型
收费全文 | 16983篇 |
免费 | 1007篇 |
国内免费 | 379篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 260篇 |
妇产科学 | 371篇 |
基础医学 | 1216篇 |
口腔科学 | 251篇 |
临床医学 | 2216篇 |
内科学 | 3285篇 |
皮肤病学 | 98篇 |
神经病学 | 280篇 |
特种医学 | 448篇 |
外科学 | 5661篇 |
综合类 | 2109篇 |
预防医学 | 588篇 |
眼科学 | 59篇 |
药学 | 992篇 |
16篇 | |
中国医学 | 211篇 |
肿瘤学 | 257篇 |
出版年
2024年 | 21篇 |
2023年 | 354篇 |
2022年 | 610篇 |
2021年 | 1002篇 |
2020年 | 1035篇 |
2019年 | 901篇 |
2018年 | 862篇 |
2017年 | 606篇 |
2016年 | 585篇 |
2015年 | 597篇 |
2014年 | 1352篇 |
2013年 | 1326篇 |
2012年 | 873篇 |
2011年 | 1010篇 |
2010年 | 833篇 |
2009年 | 802篇 |
2008年 | 739篇 |
2007年 | 687篇 |
2006年 | 621篇 |
2005年 | 520篇 |
2004年 | 493篇 |
2003年 | 395篇 |
2002年 | 350篇 |
2001年 | 259篇 |
2000年 | 239篇 |
1999年 | 157篇 |
1998年 | 155篇 |
1997年 | 127篇 |
1996年 | 112篇 |
1995年 | 106篇 |
1994年 | 87篇 |
1993年 | 72篇 |
1992年 | 76篇 |
1991年 | 32篇 |
1990年 | 37篇 |
1989年 | 34篇 |
1988年 | 52篇 |
1987年 | 45篇 |
1986年 | 30篇 |
1985年 | 26篇 |
1984年 | 24篇 |
1983年 | 17篇 |
1982年 | 26篇 |
1981年 | 15篇 |
1980年 | 16篇 |
1979年 | 15篇 |
1978年 | 9篇 |
1977年 | 6篇 |
1976年 | 8篇 |
1975年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
PurposeType B aortic dissection is a rare but life-threatening disease. Thoracic endovascular aortic repair (TEVAR) was widely used for Type B aortic dissection patients in the last decade due to the lower mortality and morbidity compared with open chest surgical repair (OCSR). AKI in type B aortic dissection is a well-recognized complication and indicates poor short-term and long-term outcome. The objective of this concise review was to identify the risk factors and the impact of AKI on type B aortic dissection patients.Methods and resultsA literature search was performed using PubMed, Embase, MEDLINE, and Cochrane Library with the search terms ‘type B aortic dissection’ and ‘acute kidney injury’ (AKI), and all English-language literatures published in print or available online from inception through August 2020 were thoroughly reviewed. Studies that reported relative AKI risks and outcomes in type B aortic dissection patient were included. Major mechanisms of AKI in type B aortic dissection included renal hypoperfusion, inflammation response, and the use of contrast medium. Type B aortic dissection patients with AKI significantly had increased hospital stay duration, need of renal replacement therapy, and 30-d and 1-year mortality.ConclusionsAKI in type B aortic dissection is a well-recognized complication and associated with poor short-term and long-term outcome. Early identification of high-risk patients, early diagnosis of AKI, stabilization of the hemodynamic parameters, avoidance of nephrotoxic drugs, and optimization of the use of contrast agents are the major strategies for the reduction of AKI in type B aortic dissection patients. 相似文献
12.
雄激素不敏感综合征(androgen insensitivity syndrome,AIS)又称为睾丸女性化综合征(testicular feminization syndrome,TFS),是一种X连锁遗传病,是男性假两性畸形中较常见的类型,可分为完全型AIS和不完全型AIS,其原因主要是雄激素受体(androgen receptor,AR)基因的突变导致其对雄激素产生抵抗和不应答。本文回顾南京医科大学附属妇产医院2例CAIS患者的临床资料及诊疗过程,以期能进一步提高对该病的认知及诊治水平。 相似文献
13.
14.
15.
16.
《Cancer cell》2021,39(11):1497-1518.e11
17.
《Foot and Ankle Surgery》2022,28(7):883-886
BackgroundStudies concerning total ankle arthroplasty could be influenced by several forms of bias. Independent national arthroplasty registries represent objective data on survival and patient reported outcomes. The aim of this study was to determine survival and identify risk factors for early failure in a nationwide series of total ankle arthroplasties from the Dutch Arthroplasty Register (LROI).Patients and methodsData of 810 patients, who received 836 total ankle arthroplasties between 2014 and 2020 were obtained from the Dutch Arthroplasty Register (LROI) with a median follow-up of 38 months (range 1–84 months). Survival was expressed in Kaplan-Meier analysis and associated hazard ratios for implant failure were determined. Implant failure was defined as the need for revision surgery for any reason or (pan)arthrodesis.ResultsDuring follow-up, we recorded 39 failures (4.7%) resulting in a implant survival of 95.3% with a median follow-up of 38 months (range 1–84 months). Medial malleolus osteotomy (HR = 2.27), previous surgery (HR = 1.83), previous osteotomy (HR = 2.82) and previous ligament reconstruction (HR = 2.83) all showed potentially clinically meaningful associations with a higher incidence of implant failure, yet only previous OCD treatment (HR = 6.21), BMI (HR = 1.09) and age (HR = 0.71) were statistically significant.InterpretationExcellent short-term survival (95.3%) with a median follow-up of 38 months was reported for TAA patients from the Dutch Arthroplasty Register. Patients with a lower age, a higher BMI or who had a prior surgical OCD treatment before TAA surgery appear to have a higher risk for revision after short-term clinical follow-up. Thorough patient selection with emphasis on risk factors associated with early implant failure might be essential to improve TAA survivorship. 相似文献
18.
19.
《Revista espa?ola de anestesiología y reanimación》2022,69(9):517-525
Background and objectivesThe ideal timing of tranexamic acid administration in total knee arthroplasty with tourniquet remains unclear. Our primary objective was to prove if administering it before surgical incision, instead of before releasing the tourniquet, reduces postoperative bleeding. A second objective was to determine whether a second dose reduces post-operative bleeding.Material and methodsA prospective, double-blind clinical trial was performed on 212 patients scheduled for total knee arthroplasty. They were randomised into 4 groups. Tranexamic acid was administered before the surgical incision in “pre-induction groups” (1 and 2), and just before the tourniquet release in “pre-release groups” (3 and 4). Groups 2 and 4 received a second dose 3 hours post-surgery. Main outcome was postoperative bleeding (visible blood loss and calculated total bleeding). Secondary outcomes were haemoglobin variations, complications and transfusion rate.ResultsThe mean calculated total bleeding was 1563 ml (95%CI: 1445 to 1681) in preinduction groups versus 1576 ml (95%CI: 1439 to 1713) in pre-release groups (P = .9); 1579 ml (95%CI: 1452 to 1706) in single-dose groups versus 1559 ml (95%CI: 1431 to 1686) in double-dose groups (P = .82). One patient was transfused. The mean haemoglobin at discharge was 10.4 g/dl (95%CI: 10.2 to 10.7) in singledose groups versus 10.8 (95%CI: 10.6 to 11.1) in double-dose groups (P = .06).ConclusionsThere were no differences in bleeding or transfusion regarding the time of tranexamic acid administration. The second dose had not impact on outcomes.Trial registration: EudraCT 2016-000071-24. 相似文献
20.